MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 05-05-2026
TransMedics Group DPO Ratio 2011-2026 | TMDX
Annual DPO Ratio TransMedics Group
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 15.5 | 23.4 | 33.5 | 64.7 | 158 | 171 | 272 | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 272 | 15.5 | 105 |
Quarterly DPO Ratio TransMedics Group
| 2026-Q1 | 2025-Q4 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 13.5 | - | 15.1 | 17.2 | - | 24.9 | 22.5 | 27.1 | - | 35.2 | 33 | 27.4 | - | 18.6 | 21.7 | 116 | - | 145 | 65 | 50.8 | - | 53.6 | 74.3 | 144 | - | 221 | 283 | 260 | - | 226 | 248 | 135 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 283 | 13.5 | 94.9 |
DPO Ratio of other stocks in the Medical devices industry
| Issuer | DPO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
GenMark Diagnostics, Inc.
GNMK
|
81.3 | - | - | $ 1.77 B |  USA |
 |
Lianluo Smart Limited
LLIT
|
10.5 | - | 24.59 % | $ 44.8 M |  China |
 |
Allied Healthcare Products
AHPI
|
23.1 | - | 3.58 % | $ 2.21 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
224 | - | -5.86 % | $ 30.6 M | USA |
 |
Apollo Endosurgery
APEN
|
63.6 | - | - | $ 475 M | USA |
 |
Alphatec Holdings
ATEC
|
73.8 | $ 7.75 | 10.8 % | $ 1.16 B | USA |
 |
EDAP TMS S.A.
EDAP
|
40.6 | $ 4.22 | 17.39 % | $ 158 M |  France |
 |
Aziyo Biologics
AZYO
|
286 | - | 1.37 % | $ 20.5 M | USA |
 |
Avinger
AVGR
|
45.5 | - | -20.74 % | $ 369 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
40.1 | - | - | $ 3.31 B | USA |
 |
BIOLASE
BIOL
|
66.7 | - | -13.19 % | $ 166 K | USA |
 |
Helius Medical Technologies
HSDT
|
362 | $ 2.19 | -1.35 % | $ 1.33 M | USA |
 |
Conformis
CFMS
|
50.4 | - | - | $ 16.4 M | USA |
 |
ClearPoint Neuro
CLPT
|
33.2 | $ 11.92 | 3.92 % | $ 338 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
79.4 | $ 17.58 | 2.69 % | $ 412 M | USA |
 |
Cardiovascular Systems
CSII
|
81.8 | - | 0.15 % | $ 844 M | USA |
 |
CryoLife, Inc.
CRY
|
41.1 | - | -4.14 % | $ 702 M | USA |
 |
LENSAR
LNSR
|
146 | $ 5.34 | -0.84 % | $ 63.9 M | USA |
 |
CHF Solutions, Inc.
CHFS
|
204 | - | 1.15 % | $ 34.5 M | USA |
 |
Cytosorbents Corporation
CTSO
|
107 | $ 0.58 | 1.75 % | $ 36.1 M | USA |
 |
LivaNova PLC
LIVN
|
68 | $ 69.97 | 5.6 % | $ 3.82 B |  Britain |
 |
Delcath Systems
DCTH
|
56 | $ 11.38 | 1.07 % | $ 408 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
131 | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
83.1 | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
48.6 | - | - | $ 111 M |  Canada |
 |
IRIDEX Corporation
IRIX
|
71.9 | $ 1.04 | 0.04 % | $ 17.6 M | USA |
 |
Dynatronics Corporation
DYNT
|
52.2 | - | 14.99 % | $ 929 K | USA |
 |
Eargo
EAR
|
124 | - | - | $ 10.2 M | USA |
 |
Myomo
MYO
|
34.8 | $ 0.88 | 3.06 % | $ 36.8 M | USA |
 |
Electromed
ELMD
|
47.8 | $ 26.74 | 3.06 % | $ 226 M | USA |
 |
Orthofix Medical
OFIX
|
76.3 | $ 12.19 | - | $ 483 M |  Curacao |
 |
Butterfly Network
BFLY
|
51.3 | $ 4.38 | -3.74 % | $ 927 M | USA |
 |
Intersect ENT, Inc.
XENT
|
72.8 | - | - | $ 955 M | USA |
 |
Second Sight Medical Products
EYES
|
29.6 | - | -0.97 % | $ 54.4 M | USA |
 |
Insulet Corporation
PODD
|
22.5 | $ 161.81 | 6.96 % | $ 11.4 B | USA |
 |
Globus Medical
GMED
|
33.1 | $ 89.04 | -0.19 % | $ 12 B | USA |
 |
Sintx Technologies
SINT
|
223 | $ 2.44 | 1.87 % | $ 6.77 M | USA |
 |
CONMED Corporation
CNMD
|
57.3 | $ 38.02 | 1.77 % | $ 1.18 B | USA |
 |
Inspire Medical Systems
INSP
|
103 | $ 47.19 | 3.11 % | $ 1.39 B | USA |
 |
Integer Holdings Corporation
ITGR
|
28.9 | $ 87.9 | 1.88 % | $ 3.05 B | USA |
 |
Invacare Corporation
IVC
|
75.6 | - | - | $ 24.7 M | USA |
 |
Stryker Corporation
SYK
|
70.1 | $ 296.38 | 1.41 % | $ 113 B | USA |
 |
Edwards Lifesciences Corporation
EW
|
58.1 | $ 83.75 | 0.67 % | $ 49 B | USA |
 |
Tandem Diabetes Care
TNDM
|
35.7 | $ 18.85 | 4.52 % | $ 1.28 B | USA |
 |
Tactile Systems Technology
TCMD
|
24.4 | $ 26.71 | 5.55 % | $ 611 M | USA |